株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のファーマコゲノミクス市場:技術別(ポリメラーゼ連鎖反応、シーケンシング、マイクロアレイ、その他)、用途別(創薬、治療)、地域別の動向と予測

Global Pharmacogenomics Market, by Technology Type (Polymerase Chain Reaction, Sequencing, Microarray, and Other Technologies), and by Application (Drug Discovery and Therapeutic Application) and by Geography - Trends and Forecast to 2025

発行 Coherent Market Insights 商品コード 664214
出版日 ページ情報 英文 210 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.43円で換算しております。
Back to Top
世界のファーマコゲノミクス市場:技術別(ポリメラーゼ連鎖反応、シーケンシング、マイクロアレイ、その他)、用途別(創薬、治療)、地域別の動向と予測 Global Pharmacogenomics Market, by Technology Type (Polymerase Chain Reaction, Sequencing, Microarray, and Other Technologies), and by Application (Drug Discovery and Therapeutic Application) and by Geography - Trends and Forecast to 2025
出版日: 2018年06月29日 ページ情報: 英文 210 Pages
概要

当レポートでは、世界のファーマコゲノミクス市場について調査し、市場の現状と成長予測、技術別、用途別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 調査目的と仮定

第2章 市場概要

第3章 市場動向、法規制、動向分析

  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
  • 影響分析
  • 疫学
  • 戦略的買収
  • 主なハイライト
  • PEST分析

第4章 技術別市場

  • イントロダクション
  • ポリメラーゼ連鎖反応
  • シーケンシング
  • マイクロアレイ
  • その他

第5章 用途別市場

  • イントロダクション
  • 創薬
  • 治療
  • 腫瘍
  • 疼痛管理
  • 神経疾患
  • その他

第6章 地域別市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • アフリカ
  • 中東

第7章 競合環境

  • ヒートマップ分析
  • 市場シェア分析
  • 企業プロファイル

第8章 セクション

目次

Pharmacogenomics is an essential research area for development of medication for pain, cancer, psychotropic, and cardiovascular disease. The success of this medication is possible through the use of innovative technologies that help define the dosage setting for subsets of the population and an individual's response to a specific drug. The success of the precision medicine is possible through the application of pharmacogenomics that uses information about a person's genes, enzyme activities, cellular environment, and proteins to diagnose and treat diseases. Rapid advancements in groups of specialized molecular diagnostic tests is contributing to the improvement for assessment of real-time treatment of diseases.

Market Dynamics

Major factors that propel the market are increasing demand for personalized drugs, increasing prevalence of several non-infectious and infectious diseases, rising utilization of these technology for effective treatment therapeutics, and growing awareness about benefits associated with pharmacogenomics. Continuous collaboration among pharmacogenomics manufacturers for various applications in clinical and translational research is also expected to drive growth of the market across regions. In 2016, Merck & Co. Inc., collaborated with Biocartis, an innovative molecular diagnostic company to develop and commercialize a new liquid biopsy technology for RAS biomarker testing. This can enable more access to the test for number of metastatic colorectal cancer patients. Furthermore, use of pharmacogenomics to perform diagnostic assays in the field of determining individual's susceptibility to certain diseases, toxicology, biochemical genetics, and drug safety are also expected to lead to rapid growth of the market for pharmacogenomics over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of pharmacogenomics and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2016 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, regulatory scenario, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global pharmacogenomics market based on the following parameters - company overview, financial performance, geographical presence, key developments and strategies, and Strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Qiagen N.V., Pacific Biosciences of California, Inc., Diatech Pharmacogenetics Srl and Assurex Health Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type up-gradation, market expansion, and marketing tactics
  • The global pharmacogenomics market report caters to various stakeholders in this industry including investors, researchers, pharmacogenomics manufacturers, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the pharmacogenomics market.

Detailed Segmentation:

  • Global Pharmacogenomics Market, By Technology Type:
    • Polymerase Chain Reaction
    • Sequencing
    • Microarray
    • Other Technologies
  • Global Pharmacogenomics Market, By Application:
    • Drug Discovery
    • Therapeutic Application
      • Oncology
      • Cardiology
      • Pain Management
      • Neurological Disorders
      • Others
  • Global Pharmacogenomics Market, By Geography:
    • North America
      • By Country:
      • U.S.
      • Canada
      • By Technology Type:
      • Polymerase Chain Reaction
      • Sequencing
      • Microarray
      • Other Technologies
      • By Application:
      • Drug Discovery
      • Therapeutic Application
      • Oncology
      • Cardiology
      • Pain Management
      • Neurological Disorders
      • Others
    • Europe
      • By Country:
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
      • By Technology Type:
      • Polymerase Chain Reaction
      • Sequencing
      • Microarray
      • Other Technologies
      • By Application:
      • Drug Discovery
      • Therapeutic Application
      • Oncology
      • Cardiology
      • Pain Management
      • Neurological Disorders
      • Others
    • Asia Pacific
      • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • By Technology Type:
      • Polymerase Chain Reaction
      • Sequencing
      • Microarray
      • Other Technologies
      • By Application:
      • Drug Discovery
      • Therapeutic Application
      • Oncology
      • Cardiology
      • Pain Management
      • Neurological Disorders
      • Others
    • Latin America
      • By Country:
      • Brazil
      • Mexico
      • Rest of Latin America
      • By Technology Type:
      • Polymerase Chain Reaction
      • Sequencing
      • Microarray
      • Other Technologies
      • By Application:
      • Drug Discovery
      • Therapeutic Application
      • Oncology
      • Cardiology
      • Pain Management
      • Neurological Disorders
      • Others
    • Middle East
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
      • By Technology Type:
      • Polymerase Chain Reaction
      • Sequencing
      • Microarray
      • Other Technologies
      • By Application:
      • Drug Discovery
      • Therapeutic Application
      • Oncology
      • Cardiology
      • Pain Management
      • Neurological Disorders
      • Others
    • Africa
      • By Country:
      • North Africa
      • Central Africa
      • South Africa
      • By Technology Type:
      • Polymerase Chain Reaction
      • Sequencing
      • Microarray
      • Other Technologies
      • By Application:
      • Drug Discovery
      • Therapeutic Application
      • Oncology
      • Cardiology
      • Pain Management
      • Neurological Disorders
      • Others
  • Company Profiles
    • Thermo Fisher Scientific Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Strategies
    • Abbott Laboratories
    • F. Hoffmann-La Roche AG
    • Qiagen N.V.
    • Pacific Biosciences of California, Inc.
    • Diatech Pharmacogenetics Srl
    • Assurex Health Inc.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Supply Side Drivers
    • Demand Side Drivers
    • Economic Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Epidemiology
    • Strategic Acquisitions
    • Key Highlights
    • PEST Analysis

4. Global Pharmacogenomics Market, By Technology Type, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018 - 2026
    • Segment Trends
  • Polymerase Chain Reaction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Microarray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Other Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)

5. Global Pharmacogenomics Market, By Application, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018 - 2026
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Therapeutic Application
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)

6. Global Pharmacogenomics Market, By Regions, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Regions, 2018 - 2026
  • North America
    • Market Size and Forecast, By Technology, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Technology, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Technology, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Technology, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Technology, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Technology, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Hoffmann-La Roche AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Qiagen N.V.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • GE Healthcare
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Pacific Biosciences of California, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Diatech Pharmacogenetics Srl
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Assurex Health Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Agena Bioscience, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Genomic Health, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top